We analyzed the data from a nationwide survey of 3,179 melanoma patients collected between 2005 and 2006 and from a 2005-2010 follow-up survey. The details were as follows : male/female ratio : 1,501/1,674, mean age : 62.5, growth pattern : ALM 444%/ SSM 19%/NM 14%/LMM 8%/mucosa 5%/ undefined 10%, UICC (2002) TNM stage : Tis 18%/Ⅰ-22%/Ⅱ-28%/Ⅲ-21%/Ⅳ-11%. The proportion of patients who received adjuvant therapy were as follows : DAVFeron : stage Ⅰ-10%, Ⅱ-50%, Ⅲ-65% : feron therapy : stage Ⅰ-16%, Ⅱ-15%, Ⅲ-17% : feron maintenance therapy : stage Ⅰ-16%, Ⅱ-29%, Ⅲ-32%. Multivariate analysis revealed that the following factors were the risk for lymph node metastasis : tumor originated in trunk (odds ratio, OR : 2.30), lower extremity (OR : 1.72), tumor with regression (OR : 2.05), increase of T classification (OR : 2.19). On the other hand, patients with LMM had lower risk of lymph node metastasis (OR : 0.39). This analysis may be useful to ascertain the present status of melanoma and improve the treatment of this disease.[
Skin Cancer (Japan) 2012 ; 27 : 195-204]
View full abstract